Free Trial
NASDAQ:SLGL

Sol-Gel Technologies (SLGL) Stock Price, News & Analysis

Sol-Gel Technologies logo
$0.77 0.00 (-0.52%)
As of 10:33 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Sol-Gel Technologies Stock (NASDAQ:SLGL)

Key Stats

Today's Range
$0.75
$0.82
50-Day Range
$0.41
$0.85
52-Week Range
$0.33
$1.65
Volume
34,119 shs
Average Volume
281,938 shs
Market Capitalization
$21.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Buy

Company Overview

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

Sol-Gel Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

SLGL MarketRank™: 

Sol-Gel Technologies scored higher than 42% of companies evaluated by MarketBeat, and ranked 531st out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sol-Gel Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Sol-Gel Technologies has received no research coverage in the past 90 days.

  • Read more about Sol-Gel Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for Sol-Gel Technologies are expected to decrease in the coming year, from ($0.28) to ($0.48) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sol-Gel Technologies is -2.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sol-Gel Technologies is -2.24, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Sol-Gel Technologies has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Sol-Gel Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    0.50% of the float of Sol-Gel Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Sol-Gel Technologies has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Sol-Gel Technologies has recently increased by 263.64%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Sol-Gel Technologies does not currently pay a dividend.

  • Dividend Growth

    Sol-Gel Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.50% of the float of Sol-Gel Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Sol-Gel Technologies has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Sol-Gel Technologies has recently increased by 263.64%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Sol-Gel Technologies has a news sentiment score of -0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.83 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Sol-Gel Technologies this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Sol-Gel Technologies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    66.51% of the stock of Sol-Gel Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 26.18% of the stock of Sol-Gel Technologies is held by institutions.

  • Read more about Sol-Gel Technologies' insider trading history.
Receive SLGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sol-Gel Technologies and its competitors with MarketBeat's FREE daily newsletter.

SLGL Stock News Headlines

Sol-Gel Announces Reverse Share Split
Sol-Gel, Mayne Pharma enter product purchase agreement
Trump Orders 'National Digital Asset Stockpile'
Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days.
See More Headlines

SLGL Stock Analysis - Frequently Asked Questions

Sol-Gel Technologies' stock was trading at $0.9301 at the beginning of 2025. Since then, SLGL shares have decreased by 18.0% and is now trading at $0.7630.
View the best growth stocks for 2025 here
.

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) posted its quarterly earnings data on Friday, August, 16th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.20) by $0.27. The business had revenue of $5.43 million for the quarter, compared to analyst estimates of $1.06 million. Sol-Gel Technologies had a negative net margin of 81.75% and a negative trailing twelve-month return on equity of 27.17%.

Sol-Gel Technologies's stock reverse split on the morning of Monday, May 5th 2025. The 1-10 reverse split was announced on Thursday, May 1st 2025. The number of shares owned by shareholders will be adjusted after the market closes on Friday, May 2nd 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Sol-Gel Technologies (SLGL) raised $60 million in an initial public offering on Thursday, February 1st 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. ​Jefferies and BMO Capital Markets​ acted as the underwriters for the IPO and JMP Securities and Raymond James​ were co-managers.

Shares of SLGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sol-Gel Technologies investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), ADMA Biologics (ADMA) and Fortress Biotech (FBIO).

Company Calendar

Last Earnings
8/16/2024
Today
5/01/2025
Next Earnings (Estimated)
5/19/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SLGL
Employees
50
Year Founded
1997

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$6.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+546.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-27,240,000.00
Pretax Margin
-81.75%

Debt

Sales & Book Value

Annual Sales
$11.71 million
Price / Cash Flow
N/A
Book Value
$1.67 per share
Price / Book
0.46

Miscellaneous

Free Float
9,330,000
Market Cap
$21.56 million
Optionable
Optionable
Beta
1.24

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:SLGL) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners